By dysregulating downstream targets involved in cell proliferation, angiogenesis, and other critical biological processes, hyperactivated STAT3 contributes to the initiation and progression of breast cancer (Ma et al., 2020; Valeta-Magara et al., 2019). This evidence concerns the gene STAT3 and breast carcinoma.